Trial
NCT00387530
Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of California, San Diego
Collaborators
National Cancer Institute (NCI)
Condition
Gastric Cancer
Intervention
oral sodium phenylbutyrate
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-02